Hepatic Steatosis in Genotype 4 Chronic Hepatitis C Patients: Implication for Therapy

BACKGROUND AND AIMThe association of hepatitis C virus genotype 4 (HCV-4) with hepatic steatosis has not been clarified. We aimed to determine the parameters associated with steatosis among HCV-4 patients and to assess the effect of steatosis on treatment with peginterferon and ribavirin. METHODSIn...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical gastroenterology 2010-11, Vol.44 (10), p.707-712
Hauptverfasser:	Khattab, Mahmoud Aboelneen, Abdel-fattah, Mohammed Emad, Eslam, Mohammed, Abdelaleem, Asharf, Abdelaleem, Rabab Atef, Shatat, Mohammed, Ali, Ahmed, Hamdy, Lamia, Tawfek, Heba
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use Biological and medical sciences Blood Pressure Body Mass Index Chi-Square Distribution Cholesterol - blood Drug Therapy, Combination Egypt Fatty Liver - blood Fatty Liver - physiopathology Fatty Liver - virology Female Gastroenterology. Liver. Pancreas. Abdomen Genotype Hepacivirus - genetics Hepatitis C, Chronic - blood Hepatitis C, Chronic - complications Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - physiopathology Human viral diseases Humans Infectious diseases Insulin Resistance Interferon-alpha - therapeutic use Liver. Biliary tract. Portal circulation. Exocrine pancreas Logistic Models Male Medical sciences Middle Aged Odds Ratio Other diseases. Semiology Polyethylene Glycols - therapeutic use Prospective Studies Recombinant Proteins Ribavirin - therapeutic use Risk Assessment Risk Factors RNA, Viral - blood Time Factors Treatment Outcome Triglycerides - blood Viral diseases Viral hepatitis Viral Load Waist Circumference
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!